ARCHIVES

Anastrozole Better Than Tamoxifen For HR+ Postmenopausal Breast Cancer, Study Finds

This article is from The Cancer Letter archive.

Vol. 28 No. 5 | May 27, 2005

Download PDF Visit The Full Archive

Related Articles

GSK Vaccine Prevents Lesions Associated With HPV

July 28, 2006

MSKCC Asked To Repay $638,371 To NIH

December 13, 1985

Recompetitions Of DCT Contracts Okayed

March 3, 1989

Survival Rates Same For Two Treatments For Eye Cancer: Radiation Or Removal

July 27, 2001

ASCO President David Johnson to oncologists: It’s time to “reconnect to our patients” and “recommit to our profession.” Horning outlines priorities.

May 20, 2005

The Clinical Trials Working Group: NCI panel considers plan to centralize clinical trial review and prioritization. NCI director faults system for duplication, “equivocal results.”

August 13, 2004